Picture of ORYZON Genomics SA logo

ORY — ORYZON Genomics SA News Story

0.000.00%
es flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Oryzon To Sponsor Phelan-McDermid Syndrome Burden Of Illness Study

Sept 22 (Reuters) - Oryzon Genomics SA ORY.MC:

TO SPONSOR FIRST PHELAN-MCDERMID SYNDROME (PMS) BURDEN OF ILLNESS STUDY

STUDY LED BY CURESHANK

Source text

Further company coverage: ORY.MC

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on ORYZON Genomics SA

See all news